Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Nexgel (NXGL) Other Operating Expenses (2019 - 2025)

Historic Other Operating Expenses for Nexgel (NXGL) over the last 6 years, with Q3 2025 value amounting to -$653000.0.

  • Nexgel's Other Operating Expenses rose 2736.37% to -$653000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 million, marking a year-over-year increase of 4305.77%. This contributed to the annual value of -$3.2 million for FY2024, which is 1693.69% down from last year.
  • Nexgel's Other Operating Expenses amounted to -$653000.0 in Q3 2025, which was up 2736.37% from -$665000.0 recorded in Q2 2025.
  • Nexgel's Other Operating Expenses' 5-year high stood at $85000.0 during Q3 2023, with a 5-year trough of -$1.9 million in Q4 2023.
  • Over the past 4 years, Nexgel's median Other Operating Expenses value was -$653000.0 (recorded in 2025), while the average stood at -$536954.0.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first skyrocketed by 9991.5% in 2021, then plummeted by 115764.71% in 2024.
  • Over the past 4 years, Nexgel's Other Operating Expenses (Quarter) stood at -$1638.0 in 2021, then plummeted by 114674.11% to -$1.9 million in 2023, then surged by 69.89% to -$566000.0 in 2024, then fell by 15.37% to -$653000.0 in 2025.
  • Its Other Operating Expenses stands at -$653000.0 for Q3 2025, versus -$665000.0 for Q2 2025 and -$712000.0 for Q1 2025.